Журнал "Гастроэнтерология" Том 58, №2, 2024
Вернуться к номеру
Dyslipidemia: therapy vectors and compromises
Авторы: I.E. Dovhaniuk, V.V. Petrushenko, N.V. Кhammash, O.Ya. Dovhaniuk
Vinnytsia National Pirogov Memorial Medical University, Vinnytsia, Ukraine
Рубрики: Гастроэнтерология
Разделы: Медицинские форумы
Версия для печати
Purpose: to optimize the basic concepts for rational compromise in dyslipidemia therapy.
Materials and methods. Insufficient level of interdisciplinary competence in correction of lipid profile prompted us to balance and substantiate vector approach in dyslipidemia therapy. Complex laboratory method, methods of systemic analysis and personal observations were used in the study.
Dyslipidemia is an integral part of “metabolic syndrome” as well as its important predictor. Hence, metabolic disorders can develop in three major directions: disturbances of carbohydrate metabolism, metabolic processes as manifestation of metabolic dysfunction-associated steatotic liver disease (MASLD), and atherogenic disorders associated with athe–rosclerotic manifestations. All types of ...